BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1724346)

  • 21. [Transrectal echography of the prostate and its value in screening for prostatic carcinoma].
    Kil PJ; Hendrikx AJ; Debruyne FM
    Ned Tijdschr Geneeskd; 1990 Feb; 134(8):385-90. PubMed ID: 2179743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of cancer of the prostate by determining the blood levels of specific prostatic antigen, rectal examination, and transrectal echography].
    Isa Kroon WA; Robles JE; de Castro F; Rosell D; Abad JI; Zudaire JJ; Berián JM
    Actas Urol Esp; 1993 Jun; 17(6):341-5; discussion 345-6. PubMed ID: 7690176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort].
    Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG
    Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
    Catalona WJ; Smith DS; Ratliff TL; Basler JW
    JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
    Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
    Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
    Silverman JM; Krebs TL
    AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI; Walsh PC; Carmichael M; Brendler CB
    JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
    Philip J; Dutta Roy S; Ballal M; Foster CS; Javlé P
    BJU Int; 2005 May; 95(7):969-71. PubMed ID: 15839915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate].
    Veneziano S; Pavlica P; Querzè R; Viglietta G; Trenta A
    Radiol Med; 1991 Jun; 81(6):857-60. PubMed ID: 1713333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
    Bourel M; Ardaillou R;
    Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of early prostatic cancer in mass screening program].
    Ohe H
    Hinyokika Kiyo; 1991 Aug; 37(8):785-8. PubMed ID: 1720271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of PSA density for the diagnosis of prostatic cancer and for the indication of radical prostatectomy].
    Doublet JD; Ciofu C; Fouret P; Gattegno B; Thibault P
    Prog Urol; 1995 Apr; 5(2):211-9, 220; discussion 219-20. PubMed ID: 7536529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for prostatic carcinoma.
    Hinman F
    J Urol; 1991 Jan; 145(1):126-9; discussion 129-30. PubMed ID: 1701495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of rectal examination, transrectal echography, CAT and MRI in the local staging of prostatic carcinoma].
    Montorsi F; Guazzoni G; Consonni P; Colombo R; Nava L; Bergamaschi F; Scattoni V; Rigatti P
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():143-5. PubMed ID: 1836654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen: questions often asked.
    Killian CS; Chu TM
    Cancer Invest; 1990; 8(1):27-37. PubMed ID: 1693541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer. Finding and managing it.
    Kemp ED
    Postgrad Med; 1992 Jul; 92(1):67-74, 77-84, 89. PubMed ID: 1377386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate specific antigen.
    Med Lett Drugs Ther; 1992 Oct; 34(880):93-4. PubMed ID: 1381807
    [No Abstract]   [Full Text] [Related]  

  • 40. Digital rectal examination-associated alterations in serum prostate-specific antigen.
    Gillenwater JY
    Am J Clin Pathol; 1992 Apr; 97(4):466-7. PubMed ID: 1372786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.